The Exchange has sought clarification from Global Health Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted declaration in case of unmodified opinion(s) The response of the Company is awaited.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Midcap 150 and 3.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE has asked Global Health Limited to clarify a compliance issue related to Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements for the quarter ended 31 March 2025. Specifically, the company has not submitted the required declaration in case of unmodified audit opinions. The company is yet to respond to the exchange's query. This appears to be a routine procedural follow-up rather than a substantive regulatory action.
This is a minor compliance formality and unlikely to have a material impact on the stock price. Investors should wait for the company's clarification, but there is no immediate cause for concern.